We are live on ! Find out more
NAII icon

Natural Alternatives International

Positive
Neutral
Negative
Sentiment 3-Months
Positive 33.3%
Neutral 33.3%
Negative 33.3%

Positive
Benzinga
8 days ago
Top 3 Risk Off Stocks That May Rocket Higher In Q3
The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.
Top 3 Risk Off Stocks That May Rocket Higher In Q3
Negative
Zacks Investment Research
1 month ago
Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure
NAII's Q3 sales rise 23% y/y, but a wider loss and margin pressure offset gains from stronger contract manufacturing demand.
Natural Alternatives Q3 Loss Widens Y/Y on Margin Pressure
Neutral
GlobeNewsWire
2 months ago
Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results
CARLSBAD, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $4.3 million, or $0.72 per diluted share, on net sales of $35.5 million for the third quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the third quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2026 Q3 and YTD Results
Neutral
Zacks Investment Research
5 months ago
Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase
NAII posts higher Q2 sales but wider losses, and trims its outlook for fiscal 2026 amid softer customer forecasts and launch delays.
Natural Alternatives Q2 Loss Widens Y/Y, Sales Increase
Neutral
GlobeNewsWire
5 months ago
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
CARLSBAD, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $2.6 million, or $0.42 per diluted share, on net sales of $34.8 million for the second quarter of fiscal year 2026 compared to a net loss of $2.2 million, or $0.37 per diluted share, in the second quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2026 Q2 and YTD Results
Positive
Zacks Investment Research
6 months ago
Niche Focus & Regulation Shape the Future of Healthcare Firms
CPIX, NAII and ICCC lean into specialization, compliance and targeted growth to thrive in the niche healthcare markets.
Niche Focus & Regulation Shape the Future of Healthcare Firms
Neutral
GlobeNewsWire
8 months ago
Natural Alternatives International, Inc. Announces 2026 Q1 Results
CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $0.3 million, or $0.05 per diluted share, on net sales of $37.7 million for the first quarter of fiscal year 2026 compared to a net loss of $2.0 million, or $0.33 per diluted share, in the first quarter of the prior fiscal year.
Natural Alternatives International, Inc. Announces 2026 Q1 Results
Positive
Zacks Investment Research
8 months ago
Zacks Initiates Coverage of NAII With Neutral Recommendation
Discover why Zacks, being the first on Wall Street to initiate the stock coverage, rates CFFI as "Neutral." Explore how Natural Alternatives' expansion, innovation and prudent management balance growth potential with margin and execution challenges in a dynamic supplement market.
Zacks Initiates Coverage of NAII With Neutral Recommendation
Neutral
GlobeNewsWire
10 months ago
Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results
CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced a net loss of $7.2 million, or ($1.20) per diluted share, on net sales of $33.9 million for the fourth quarter of fiscal year 2025 compared to a net loss of $1.9 million, or ($0.32) per diluted share, in the fourth quarter of the prior fiscal year. Our net loss for the fourth quarter of fiscal 2025 included non-recurring non-cash charges of $1.4 million related to the settlement of a litigation matter and a $4.8 million valuation allowance against our net deferred tax assets. Excluding these charges, our net loss for the fourth quarter of fiscal 2025 would have been $1.0 million.
Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results
Neutral
GlobeNewsWire
1 year ago
Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company
CARLSBAD, Calif., July 21, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (“NAI”) (NASDAQ:NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, announced it has extended its partnership with The Juice Plus+ Company (“Juice Plus+”), a globally recognized leader in plant-based whole-body nutritional products, through the execution of a new multi-year Manufacturing Agreement covering Juice Plus+ capsule and powder products sold in over 24 markets around the world.
Natural Alternatives International, Inc. Announces New Manufacturing Agreement with The Juice Plus+® Company